Skip to main content

Table 4 The association of biochemical and clinical parameters with prevalence of prediabetes based on the adjusted analyses—logistic regression model among participants: The Hoveyzeh Cohort Study

From: Prevalence of prediabetes and associated factors in southwest iran: results from Hoveyzeh cohort study

Variables Male Female Total
▀Adjusted OR (95%CI) P ▀Adjusted OR (95%CI) p ▀Adjusted OR (95%CI) P
Triglyceride (mg/dl) (≤ 150 mg/dl)
 150-199 mg/dl 1.06 (0.85,1.33) 0.6 1.32(1.11,1.58) 0.002 1.32(1.16,1.51)  < 0.001
  ≥ 200 mg/dl 1.36 (1.11,1.67) 0.03 1.73(1.44,2.07)  < 0.001 1.64(1.44,1.86)  < 0.001
Cholesterol (≤ 200 mg/dl)
 200–239 mg/dl 1.18(1.01,1.44)  < 0.001 1.18 (1.01,1.38) 0.042 1.33 (1.18,1.49)  < 0.001
  ≥ 240 mg/dl 2 (1.5, 2.68)  < 0.001 1.53 (1.22,1.91)  < 0.001 2.04 (1.72,2.42)  < 0.001
HDL-C (Normal)*
 Abnormal* 0.91 (0.75,1.105) 0.35 1.035 (0.9,1.19) 0.63 1.04(0.93,1.16) 0.47
Systolic Blood Pressure (≤ 140 mmHg)
  ≥ 140 mmHg 1.48 (1.11,1.98) 0.008 1.39 (1.07,1.82) 0.014 1.95(1.62,2.35)  < 0.001
Diastolic Blood Pressure (≤ 90 mmHg)
  ≥ 90 mmHg 1.14 (0.84,1.55) 0.38 1.31 (0.98,1.76) 0.011 1.54(1.26,1.89)  < 0.001
 GOT 1.016 (1.007,1.026) 0.001 1.012 (1.003,1.02) 0.005 1.013 (1.007,1.019) 0.001
 GPT 1.009 (1.005,1.014)  < 0.001 1.012 (1.006,1.017)  < 0.001 1.01 (1.006,1.013)  < 0.001
  1. HDL-C High-density Lipoprotein Cholesterol, GOT Glutamic Oxaloacetic transaminase, GPT Glutamic pyruvic transaminase
  2. *For male: HDL-C < 40 mg/dl, for women < 50 mg/dl
  3. Normal HDL-C is defined as HDL-C ≥ 40 (in men) and ≥ 50 mg/dl (in women)
  4. OR Odds ratio, CI Confidence Interval
  5. P-value < 0.05 was considered significant
  6. Adjusted for all variables in Table 3 (age real, Marital status, wealth scores, smoking cigarette, Alcohol drinker, history of CI, MI, and stroke, Body Mass Index, PA, and daily energy intake)